TrialPath

Find a study

Browse recruiting studies near you — free to check, always your choice.

Match me to a study

141 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

  • Migraine / chronic headache

    BOTOX® vs. XEOMIN® for Chronic Migraine

    Comparing two injections to treat chronic migraine

    📍 Naval Medical Center Camp Lejeune · Jacksonville, NC · Get directions →

    Chronic migraine (CM) is a disabling disorder that sidelines active duty personnel and diminishes their quality of life. It affects 1.3% to 2.4% of the general population.

    ✓ Study care freePhase 3Ages 18–89Learn more →
  • Migraine / chronic headache

    Migraine in Adolescents

    Studying what brain and behavior factors can predict migraine onset in adolescents

    📍 Washington University School of Medicine · St Louis, MO · Get directions →

    Aim 1. To identify psychophysical and neural factors predicting migraine onset in adolescents Aim 2a.

    ✓ Study care freeAges 10–13Learn more →
  • Migraine / chronic headache

    Responding With Evidence and Access for Childhood Headaches

    Testing how well headache prevention options and telehealth CBT work for youth with migraine

    📍 University of Alabama at Birmingham Children's of Alabama · Birmingham, AL · +14 more US sites · Get directions →

    This comparative effectiveness study will clarify current first-line preventive treatment approaches for use by neurologists, psychologists, and primary care providers in the context of real world care, and will demonstrate the feasibility of Cognitive Behavioral Therapy (CBT) via telehealth for youth with migraine. The focus is on applying evidence-based care and enhancing access to it.

    ✓ Study care freeAges 10–17Learn more →
  • Migraine / chronic headache

    Supraspinal Processing of Sensory Aspects of Pain

    Studying how the brain processes pain in children with migraine

    📍 Cincinnati Children's Hospital · Cincinnati, OH · Get directions →

    The goal of this basic science study is to learn about the brain mechanisms of chronic pain across different chronic pain syndromes in pediatric patients. The main questions it aims to answer are: * Are there shared and distinct brain systems engaged by different forms of pediatric chronic pain?

    ✓ Study care freeAges 10–17Learn more →
  • Fatty liver disease (NASH/MASH)

    📍 Arizona Liver Health · Chandler, AZ · +1 more US site · Get directions →

    This study is researching an experimental drug called ALN-CIDEB, also referred to as "study drug". The study is focused on participants with metabolic dysfunction-associated steatotic liver disease (MASLD) (Part A) and metabolic dysfunction-associated steatohepatitis (MASH) (Part B).

    ✓ Study care freePhase 1Ages 18–65Learn more →
  • Fatty liver disease (NASH/MASH)

    NAFLD Clinical Care Pathway

    Testing a care plan for people with non-alcoholic fatty liver disease

    📍 Michael E. DeBakey VA Medical Center, Houston, TX · Houston, TX · Get directions →

    Non-alcoholic fatty liver disease (NAFLD) is a new condition that has become the most common chronic liver disease in the world and a main cause of liver cirrhosis, liver failure and liver cancer. Obesity and diabetes, conditions that are very common among Veterans are the main risk factors for NAFLD.

    ✓ Study care freeAges 18+Learn more →
  • Fatty liver disease (NASH/MASH)

    A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat

    Testing a new medicine for liver disease in adults with extra body fat

    📍 Altasciences Clinical Company, Inc · Montreal, Quebec · Get directions →

    The purpose of this clinical study is to find out if NNC4005-0001 is well-tolerated and safe for people who have increased body weight and increased liver fat. Participants will receive either NNC4005-0001, which is the treatment being tested, or a placebo, which is a treatment that contains no active medicine.

    ✓ Study care freePhase 1Ages 18–69Learn more →
  • Migraine / chronic headache

    RELAXaHEAD for Headache Patients (Phase III)

    Testing a remote program called RELAXaHEAD for people with migraine

    📍 NYU Langone Health · New York, NY · Get directions →

    This study is a fully powered, remote randomized control trial to evaluate RELAXaHEAD in people with migraine.

    ✓ Study care freeAges 16–80Learn more →
  • Fatty liver disease (NASH/MASH)

    A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

    Testing how efimosfermin alfa compares with placebo for MASH with scarred liver tissue

    💵 May compensate

    📍 GSK Investigational Site · Arcadia, CA · +39 more US sites · Get directions →

    The purpose of this study is to assess the safety and efficacy of efimosfermin alfa in the resolution of steatohepatitis and improvement of liver-related clinical outcome compared to placebo in individuals with MASH and biopsy-confirmed F2- or F3-stage fibrosis.

    ✓ Study care freePhase 3Ages 18–75Learn more →
  • Migraine / chronic headache

    A Study of Eptinezumab in Pediatric Participants With Episodic Migraine

    Testing whether eptinezumab lowers the number of days with episodic migraine in children

    📍 Ki Health Partners LLC DBA New England Institute for Clinical Research · Stamford, CT · +14 more US sites · Get directions →

    The main goal of this trial is to learn whether eptinezumab helps reduce the number of days with episodic migraine in pediatric participants.

    ✓ Study care freePhase 3Ages 6–17Learn more →
  • Type 2 diabetesFatty liver disease (NASH/MASH)

    A Phase 1b Study of QX1206 in T2DM Patients With NAFLD

    Testing QX1206 in people with type 2 diabetes and fatty liver

    📍 Centricity Research Toronto LMC. · Toronto, · Get directions →

    This is an open label phase 1b trial of QX1206 in patients with T2DM and with NAFLD. Laboratory tests and other measurements will be assessed prior to the first dose of study treatment and throughout the study to determine the recommended phase 2 dose.

    ✓ Study care freePhase 1Ages 18–64Learn more →
  • Migraine / chronic headache

    Efficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents

    Comparing Xeomin injections for migraine in people with TBI vs others

    📍 National Intrepid Center of Excellence (NICOE) · Bethesda, MD · Get directions →

    This cohort study aims to compare the efficacy of Xeomin injections for migraine management in patients with a history of Traumatic Brain Injury (TBI) versus those with a history of Anomalous Health Incidents (AHI). The study will be conducted at the National Intrepid Center of Excellence (NICOE) in Bethesda, MD.

    ✓ Study care freeAges 18+Learn more →
  • Fatty liver disease (NASH/MASH)

    Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis

    Testing a non-invasive ultrasound way to measure liver fat percentage

    📍 University of Washington · Seattle, WA · Get directions →

    The research study is considering a non-invasive way to measure the percentage of fat in the liver using ultrasound. This could help detect early signs of a very common condition called metabolic dysfunction-associated steatotic liver disease (MASLD).

    ✓ Study care freeAges 18–75Learn more →
  • Fatty liver disease (NASH/MASH)

    Androgens and NAFLD Longitudinal Cohort Study

    Studying how male-type sex hormones may affect NAFLD in young women over time

    📍 University of California San Francisco · San Francisco, CA · +1 more US site · Get directions →

    The researchers want to learn how androgens, a type of sex hormone, might affect nonalcoholic fatty liver (NAFLD) in young women over time. NAFLD happens when fat builds up in the liver which can cause damage to the liver such as inflammation or scarring.

    ✓ Study care freeAges 18–42WomenLearn more →
  • Fatty liver disease (NASH/MASH)

    📍 Arizona Liver Health · Chandler, AZ · +39 more US sites · Get directions →

    The primary objective of this trial is to evaluate the dose-dependent and comparative effects of ECC4703 (low and high dose), ECC0509 (low and high dose), and their combination on hepatic fat reduction as assessed by change in magnetic resonance imaging proton density fat fraction (MRI-PDFF) at Week 12.

    ✓ Study care freePhase 2Ages 18–75Learn more →
  • Migraine / chronic headache

    BE WELL With Migraine: Brain Education and WELLness With Migraine

    Testing two different online non-drug programs for people with migraine

    📍 Cambridge Health Alliance - Center for Mindfulness and Compassion · Cambridge, MA · +2 more US sites · Get directions →

    The goal of this randomized clinical trial is to evaluate two different non-drug, virtual treatment options designed to improve the lives of patients with migraine. Both interventions involve 8 weekly sessions and an online platform with additional content and learning.

    ✓ Study care freeAges 18+Learn more →
  • Migraine / chronic headache

    Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US

    Testing rimegepant taken before a known trigger to prevent predictable migraine

    📍 MedStar Health: Neurology at McLean · McLean, VA · Get directions →

    Single-center, open label, prospective study conducted at Medstar Georgetown Headache Center. Men and woman ≥ 18 years old that are diagnosed with migraine with or without aura for at least 1 year, who report a reliable migraine trigger.

    ✓ Study care freePhase 4Ages 18+Learn more →
  • Migraine / chronic headache

    Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

    Testing rimegepant versus placebo as a migraine prevention in kids

    📍 The Belinga Clinic · Fort Smith, AR · +39 more US sites · Get directions →

    The purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and adolescents ≥ 6 to \<18 years with episodic migraine.

    ✓ Study care freePhase 3Ages 6–17Learn more →
  • Migraine / chronic headache

    Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks

    Testing how well an oral migraine medicine works during the early warning phase

    📍 Neurology and Pain Specialty Center /ID# 278508 · Aliso Viejo, CA · +2 more US sites · Get directions →

    Migraine is a neurological disease characterized by moderate or severe headaches, associated with nausea, vomiting, and/or sensitivity to light and sound. This study will assess changes in migraine attack severity for adult participants treating with oral ubrogepant across migraine attacks.

    ✓ Study care freeAges 18+Learn more →
  • Migraine / chronic headache

    Emgality for Migraine in Breastmilk

    Studying whether a migraine medicine gets into breast milk and affects babies

    📍 University of California, San Francisco · San Francisco, CA · Get directions →

    The goal of this project is to evaluate galcanezumab transfer into maternal breastmilk, and to evaluate infant (growth, development, constipation, colic, infections) and maternal (headache) outcomes for dyads in which the mother was treated with galcanezumab and to compare outcomes for infants who were or were not breastfed after maternal treatment. In this prospective observational study, the study team proposes to prospectively collect serial milk samples from 30 adult women who are treated with galcanezumab for migraine.

    ✓ Study care freeAges 18–45WomenLearn more →
  • DepressionAnxietyMigraine / chronic headache

    External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy

    Studying how safe and helpful external nerve stimulation is for migraine in pregnant women

    📍 https://public.smart-trial.co/#/public/649d77f0e8f8d0fb993d0c61/6626f6a04f0a3c7dd0860e14/662726d84f0a3c7dd08aeaa0/signup?lang=en-us&enforceLanguage=true · Darien, CT · Get directions →

    This online registry aims to understand the potential benefits and safety of external trigeminal nerve stimulation for the treatment of migraine in pregnant women. Women do not need to use external trigeminal nerve stimulation or any other form of migraine treatment to participate in the registry.

    ✓ Study care freeAges 18–44WomenLearn more →
  • Migraine / chronic headache

    Acceptance and Commitment Therapy to Improve Disability in Chronic Migraine

    Testing whether Acceptance and Commitment Therapy helps adults with chronic migraine function better

    📍 Brigham and Women's / Faulkner Hospital · Boston, MA · Get directions →

    The goal of this clinical trial is to learn if the behavioral treatment called Acceptance and Commitment Therapy (ACT) works to improve disability in adults with chronic migraine. The main questions it aims to answer are: Does the use of ACT added to usual treatment improve scores on questionnaires designed to measure daily functioning and activity?

    ✓ Study care freeAges 18–65Learn more →
  • Migraine / chronic headache

    Cocoa Extract for Migraine Trial

    Testing whether people with episodic migraine can stick to high-dose cocoa extract

    📍 Brigham and Women's Hospital · Boston, MA · Get directions →

    The goal of this clinical trial is to assess the feasibility of recruitment and adherence to a high-dose cocoa extract supplement in individuals diagnosed with episodic migraine. The main questions it aims to answer are: * Will we be able to enroll 114 participants during the recruitment period?

    ✓ Study care freeAges 18+Learn more →
  • Migraine / chronic headache

    A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

    Testing an oral medicine to track side effects and migraine changes in teens aged 12 to 17

    📍 Rehabilitation and Neurological Services /ID# 270782 · Huntsville, AL · +30 more US sites · Get directions →

    Migraine is a disease that most often causes moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other symptoms.

    ✓ Study care freePhase 3Ages 12–17Learn more →
  • Fatty liver disease (NASH/MASH)

    Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)

    Testing whether daily soy milk affects liver disease in children with fatty liver

    📍 Cincinnati Children's Hospital Medical Center · Cincinnati, OH · Get directions →

    A randomized, controlled study of standard soy milk consumption compared to 2% fat cow's milk consumption in children with Non-alcoholic Fatty Liver Disease (NAFLD). The investigators hypothesize that the daily consumption of soy isoflavones found in the soy milk will be beneficial in reducing NAFLD and other obesity-related comorbidities.

    ✓ Study care freePhase 2Ages 5–12Learn more →
  • Migraine / chronic headache

    Investigating Brain Function in People With and Without Visual Snow Syndrome Using Adaptation to Visual Stimuli

    Studying how brain activity changes with visual images in people with visual snow syndrome or

    📍 University of Minnesota · Minneapolis, MN · Get directions →

    The goal of this study is to learn more about the brain pathways and activity involved in creating Visual Snow Syndrome (VSS). The main questions it aims to answer are: * Does VSS arise from spontaneous activity in brain pathways?

    ✓ Study care freeAges 18–60Learn more →
  • Obesity / overweightFatty liver disease (NASH/MASH)

    Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

    Testing an endoscopic stomach procedure for people with obesity and MASH

    📍 Brigham and Women's Hospital · Boston, MA · +1 more US site · Get directions →

    Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease globally. While weight loss through lifestyle modification is the standard treatment, most patients regain weight limiting ultimate improvement in liver disease.

    ✓ Study care freeAges 18+Learn more →
  • Migraine / chronic headache

    Aimovig Pregnancy Exposure Registry

    Tracking birth defects in babies of pregnant women with migraine who take Aimovig

    📍 IQVIA Virtual Site · Durham, NC · Get directions →

    The primary objective of this study is to estimate the proportion of major congenital malformations in infants of women with migraine exposed to erenumab-aooe during pregnancy compared to infants of women with migraine unexposed to erenumeb-aooe.

    ✓ Study care freeAges 18–99WomenLearn more →
  • Migraine / chronic headache

    A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine

    Testing rimegepant tablets in adolescents with frequent migraine

    📍 Xenoscience Inc · Phoenix, AZ · +26 more US sites · Get directions →

    The purpose of this study is to learn about the effect of a study medicine called rimegepant in adolescents who have frequent migraine attacks. Rimegepant is a tablet that dissolves when you put it on or under your tongue.

    ✓ Study care freePhase 3Ages 12–17Learn more →
  • Migraine / chronic headache

    Endometriosis and Migraine

    Comparing pain and sex hormone levels in people with migraine and/or endometriosis

    📍 Washington University School of Medicine · St Louis, MO · Get directions →

    This study aims to determine differences in experimental pain and sex hormone levels between patients with migraine, patients with endometriosis, patients with migraine and endometriosis, and healthy controls. Participants will complete surveys, experimental pain paradigms and collection of samples for hormone analyses.

    ✓ Study care freeAges 12–45WomenLearn more →
  • Fatty liver disease (NASH/MASH)

    A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

    Testing a drug to treat fat buildup liver disease in people with stage 2 or 3 fibrosis

    📍 Akero Clinical Study Site · Birmingham, AL · +39 more US sites · Get directions →

    This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with non-cirrhotic NASH/MASH and fibrosis stage 2 or 3 (F2 or F3). The study will enroll subjects in two cohorts for a total samples size of 1650 subjects.

    ✓ Study care freePhase 3Ages 18–80Learn more →
  • Fatty liver disease (NASH/MASH)

    Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

    Testing how the liver responds to glucose in fatty liver disease, and semaglutide’s effect

    💵 May compensate

    📍 National Institutes of Health Clinical Center · Bethesda, MD · Get directions →

    Background: In non-alcoholic fatty liver disease (NAFLD), fat accumulates in the liver and can cause damage. Researchers want to learn what causes the damage NAFLD, and to see if a medication can help.

    ✓ Study care freePhase 2Ages 18–100Learn more →
  • Fatty liver disease (NASH/MASH)

    📍 Arizona Liver Health - Chandler · Chandler, AZ · +30 more US sites · Get directions →

    Rivus Pharmaceuticals. Inc. is sponsoring this research study to assess the safety and tolerability of HU6 as a possible treatment for patients diagnosed with metabolic dysfunction-associated steatohepatitis (MASH). The study will also asse

    ✓ Study care freePhase 2Ages 30+Learn more →
  • Fatty liver disease (NASH/MASH)

    A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

    Testing whether two doses of pegozafermin are safe and work for liver scarring in adults with MASH

    📍 89bio Clinical Study Site · Birmingham, AL · +39 more US sites · Get directions →

    The study will assess the efficacy and safety of 2 dose regimens of pegozafermin compared to placebo for the treatment of liver fibrosis stage F2 or F3 in adult participants with MASH.

    ✓ Study care freePhase 3Ages 18–80Learn more →
  • Obesity / overweightFatty liver disease (NASH/MASH)

    Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity

    Studying how a fat-tissue immune cell controls fat breakdown in obesity

    📍 University of Missouri School of Medicine · Columbia, MO · Get directions →

    The goal of this study is to evaluate the role of transcription factor EB (TFEB) in adipose (fat) tissue macrophages (ATM) in regulating adipose tissue and systemic metabolic function in obesity. The investigators will assess the differences in ATM lipid metabolism in people with metabolically abnormal obesity and lean individuals.

    ✓ Study care freeAges 18–70Learn more →
  • Migraine / chronic headache

    A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    Testing whether elismetrep works and is safe for treating migraine attacks

    📍 Central Research Associates, LLC (CRA) dba Flourish Research · Birmingham, AL · +39 more US sites · Get directions →

    This is a double-blind, randomized, multicenter, outpatient evaluation of the efficacy, safety, and tolerability of elismetrep, as compared with placebo, in the acute treatment of migraine.

    ✓ Study care freePhase 3Ages 18–75Learn more →
  • Obesity / overweightFatty liver disease (NASH/MASH)

    Human Models of Selective Insulin Resistance: Alpelisib, Part I

    Testing how insulin works in healthy people versus people at risk for type 2 diabetes

    💵 May compensate

    📍 Columbia University Irving Medical Center · New York, NY · Get directions →

    The goal of this clinical trial is to understand how the blood sugar-lowering hormone insulin works in healthy adults versus those who are at risk for type 2 diabetes. The study will use a drug called alpelisib, which interferes with insulin's actions in the body, to answer the study's main question: does the liver continue to respond to insulin's stimulation of fat production even when it loses the ability to stop making glucose (sugar) in response to insulin.

    ✓ Study care freePhase 1Ages 18–70Learn more →
  • Fatty liver disease (NASH/MASH)

    Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease

    Testing how SGLT2 inhibitors work for fatty liver disease in obese teens

    💵 May compensate

    📍 Ann & Robert H Lurie Children's Hospital of Chicago · Chicago, IL · Get directions →

    This study is a randomized, double-blind, placebo-controlled trial specifically designed to evaluate the preliminary feasibility, initial efficacy and safety of SGLT2 inhibitors for treating NAFLD in adolescents with obesity.

    ✓ Study care freePhase 2Ages 16–20Learn more →
  • Migraine / chronic headache

    A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

    Testing a medicine shot to treat episodic migraine vs placebo

    📍 Flourish - Birmingham · Birmingham, AL · +15 more US sites · Get directions →

    The purpose of this Phase 2 study is to evaluate the safety and efficacy of SC MEDI0618 compared to placebo in participants with episodic migraine.

    ✓ Study care freePhase 2Ages 18–70Learn more →
  • Migraine / chronic headache

    A Feasibility Trial of Virtual Reality Neurofeedback for Adolescents With Migraine

    Testing a home virtual reality program that uses brain feedback for teens with migraine

    📍 Children's Mercy · Kansas City, MO · Get directions →

    The goal of this clinical trial is to learn whether a home-based virtual reality (VR) neurofeedback program is feasible and acceptable for adolescents with migraine. The study will also explore whether the program may improve headache-related outcomes.

    ✓ Study care freeAges 10–16Learn more →
  • Migraine / chronic headache

    Study of EVO756 in Adults With Migraine

    Testing a medicine called EVO756 compared with placebo in adults with migraine

    📍 CA Medical Clinic for Headache · Los Angeles, CA · +12 more US sites · Get directions →

    This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.

    ✓ Study care freePhase 2Ages 18–64Learn more →
  • Migraine / chronic headache

    📍 Rehabilitation & Neurological Services /ID# 229969 · Huntsville, AL · +39 more US sites · Get directions →

    Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in children.

    ✓ Study care freePhase 3Ages 6–17Learn more →
  • Migraine / chronic headache

    MMA Embolization for Refractory Chronic Migraine

    Testing safety and effectiveness of a brain artery embolization for chronic migraine

    📍 Barrow Neurological Institute at St. Joseph's Hospital · Phoenix, AZ · +8 more US sites · Get directions →

    This is a prospective, multi-center, feasibility study to investigate safety and effectiveness of TRUFILL n-BCA liquid embolic system in bilateral middle meningeal artery (MMA) embolization for the treatment of refractory chronic migraine.

    ✓ Study care freeAges 18–65Learn more →
  • Obesity / overweightFatty liver disease (NASH/MASH)

    Fibrosis Lessens After Metabolic Surgery

    Testing whether metabolic surgery can reduce liver scarring in obesity

    💵 May compensate

    📍 Banner Health Center · Phoenix, AZ · +3 more US sites · Get directions →

    Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), a major global public health concern, is commonly associated with obesity, diabetes, and dyslipidemia. MASLD is currently the most common cause of chronic liver disease affecting about 80% of people with obesity, ranging from simple fat deposits in the liver to Metabolic Dysfunction-Associated Steatohepatitis (MASH), cellular injury, advanced fibrosis, cirrhosis, or hepatocellular carcinoma.

    ✓ Study care freePhase 4Ages 18–75Learn more →
  • Fatty liver disease (NASH/MASH)

    A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

    Testing whether pegozafermin is safe and works for MASH-related liver cirrhosis

    💵 May compensate

    📍 89bio Clinical Study Site · Birmingham, AL · +39 more US sites · Get directions →

    The study will assess the efficacy and safety of pegozafermin administered in participants with compensated cirrhosis due to MASH (biopsy-confirmed fibrosis stage F4 MASH \[previously known as nonalcoholic steatohepatitis, NASH\]).

    ✓ Study care freePhase 3Ages 18–75Learn more →
  • Migraine / chronic headache

    Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines

    Testing whether adding magnesium to prochlorperazine reduces migraine pain

    📍 Advocate Christ Medical Center Emergency Department · Oak Lawn, IL · Get directions →

    The purpose of this research study is to find out if using magnesium in addition to prochlorperazine will help reduce your migraine pain.

    ✓ Study care freePhase 3Ages 18+Learn more →
  • Migraine / chronic headache

    Chiropractic Care for Episodic Migraine

    Testing whether chiropractic care helps people with episodic migraine

    📍 Osher Center for Integrative Health, Mass General Brigham · Boston, MA · Get directions →

    Migraine, a chronic intermittent headache disorder, ranks in the top five causes of years lived with disability. One promising non-pharmacologic and integrative treatment for migraine may be chiropractic care due to the co-occurrence of migraine and musculoskeletal complaints.

    ✓ Study care freeAges 18–65Learn more →
  • Fatty liver disease (NASH/MASH)

    A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

    Testing efimosfermin in people with MASH-related compensated cirrhosis

    💵 May compensate

    📍 GSK Investigational Site · Chandler, AZ · +29 more US sites · Get directions →

    The purpose of this study is to evaluate the safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of efimosfermin in participants with metabolic dysfunction associated steatohepatitis (MASH) and compensated cirrhosis consistent with stage F4 fibrosis.

    ✓ Study care freePhase 2Ages 18–75Learn more →
  • Fatty liver disease (NASH/MASH)

    NASH AMPK Exercise Dosing (AMPED) Trial

    Testing how much exercise may help people with nonalcoholic fatty liver disease

    📍 Penn State Hershey Medical Center · Hershey, PA · Get directions →

    There is no known cure or regulatory agency approved drug therapy for nonalcoholic fatty liver disease (NAFLD), the leading cause of liver disease worldwide, and its progressive type, NASH. This places increased importance on using exercise to treat NAFLD.

    ✓ Study care freeAges 18–69Learn more →
  • Migraine / chronic headache

    Mechanistic Studies of Psilocybin in Headache Disorders

    Testing how psilocybin may affect migraine headache symptoms

    📍 VA Connecticut Healthcare System · West Haven, CT · Get directions →

    In previous clinical trial work, the investigators observed lasting reductions in headache burden after limited dosing of psilocybin. This purpose of this study is to examine potential sources for this observed effect.

    ✓ Study care freeEarly Phase 1Ages 21–70Learn more →
  • Migraine / chronic headache

    Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant

    Studying pregnancy and baby outcomes after migraine medicine exposure

    📍 Evidera, a PPD business unit · Wilmington, NC · Get directions →

    The purpose of the study is to evaluate fetal, maternal, and infant outcomes through 12 months of age.

    ✓ Study care freeWomenLearn more →
  • Obesity / overweightFatty liver disease (NASH/MASH)

    Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease

    Testing how well endoscopic ultrasound stiffness imaging finds liver scarring in people with fatty

    📍 Brigham and Women's Hospital · Boston, MA · +1 more US site · Get directions →

    The goal of this observation study is to assess whether endoscopic ultrasound shear wave elastography (EUS-SWE) may be a useful tool for liver fibrosis screening in patients with elevated body mass index and non alcoholic fatty liver disease as compared to other non-invasive screening modalities, which have traditionally had less accurate results in this population. The main questions it aims to answer are: * Determine accuracy of EUS-SWE for liver fibrosis screening compared to other non-invasive scoring systems, such as the FIB-4 score and Fibroscan in patients with elevated body mass index * Establish optimal stiffness (kPa) cutoffs for liver fibrosis grading for EUS-SWE for this patient population in reference to the gold standard liver biopsy, as no standard cutoffs currently exist.

    ✓ Study care freeAges 18+Learn more →
  • Migraine / chronic headache

    Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy

    Tracking pregnancy outcomes and side effects in women with migraine taking Ubrelvy or Qulipta

    📍 Iqvia /Id# 266904 · Durham, NC · Get directions →

    Migraine is a common neurological disorder typically characterized by attacks of throbbing or pulsating headache on one side of the head of moderate to severe pain intensity. The purpose of this study is to evaluate fetal, maternal, and infant outcomes through 12 months of age among women exposed to Ubrelvy or Qulipta during pregnancy, as well as in 2 comparator groups.

    ✓ Study care freeAges 18+WomenLearn more →
  • Fatty liver disease (NASH/MASH)

    Rezdiffra Pregnancy and Lactation Registry

    Tracking pregnancy and baby outcomes after exposure to Rezdiffra in women with NASH

    📍 Madrigal Pharmaceuticals · West Conshohocken, PA · Get directions →

    To evaluate pregnancy and clinical outcomes in women with NASH and their infants after exposure to Rezdiffra at any time during pregnancy and/or lactation.

    ✓ Study care freeWomenLearn more →
  • Fatty liver disease (NASH/MASH)

    Evaluating the Pharmacokinetics and Safety of Miricorilant

    Testing how a drug works in the body and its safety in adults with MASH

    💵 May compensate

    📍 Site# 433 · San Antonio, TX · Get directions →

    A Phase 1b, Open-Label Study Evaluating the Pharmacokinetics and Safety of Miricorilant in Adult Patients With Presumed Metabolic Dysfunction-Associated Steatohepatitis (MASH)

    ✓ Study care freePhase 1Ages 18–75Learn more →
  • Fatty liver disease (NASH/MASH)

    Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAFLD

    Testing a medicine at two doses for safety and effects on fats in people with high triglycerides and

    💵 May compensate

    📍 OrsoBio Research Site · Guadalajara, Jalisco · Get directions →

    This is a Phase 2a, randomized, double-blind, placebo-controlled study evaluating the safety, tolerability, and efficacy of 2 dose levels of TLC-2716 in subjects with hypertriglyceridemia and nonalcoholic fatty liver disease as assessed by changes in fasting triglycerides, liver steatosis by MRI, and other biomarkers.

    ✓ Study care freePhase 2Ages 18–70Learn more →
  • Fatty liver disease (NASH/MASH)

    Bicalutamide Therapy in Young Women With NAFLD and PCOS

    Testing bicalutamide in young women with fatty liver inflammation (NASH) and PCOS

    📍 University of California San Francisco · San Francisco, CA · Get directions →

    Nonalcoholic steatohepatitis (NASH), or fat-related liver inflammation and scarring is projected to be the leading cause of cirrhosis in the United States (U.S.) within the next few years. Women are at disproportionate risk for NASH, with approximately 15 million U.S.

    ✓ Study care freePhase 1Ages 18–42WomenLearn more →
  • Fatty liver disease (NASH/MASH)

    Thermoacoustic Method for Estimating Liver Fat Fraction

    Testing a new ultrasound method to measure liver fat compared with MRI

    📍 ENDRA Life Sciences · Ann Arbor, MI · Get directions →

    The goal of this study is to use our Thermoacoustic Enhanced Ultrasound device to measure the fat levels in your liver and compare it to the the gold standard MRI PDFF measurements. Participants will have a scan with our device, then they will go have an abdominal MRI completed.

    ✓ Study care freeAges 18+Learn more →
  • Fatty liver disease (NASH/MASH)

    Endoscopic Ultrasound Shear Wave Elastography Study

    Testing an ultrasound imaging method during endoscopy to measure liver scarring

    💵 May compensate

    📍 Brigham and Women's Hospital · Boston, MA · +1 more US site · Get directions →

    This study shall be a prospective, multicenter, single arm, consecutive, interventional study conducted in a post-market setting using commercially available devices. Consecutive, eligible patients with clinical suspicion of MASLD or MASH reporting for an endoscopic ultrasound and liver biopsy for evaluation of fibrosis will be enrolled.

    ✓ Study care freeAges 18+Learn more →
  • Migraine / chronic headache

    A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache

    Comparing a migraine medicine tablet that dissolves in the mouth to another for adults with migraine

    📍 Maimonides Medical Center · Brooklyn, NY · Get directions →

    Rimegepant (Nurtec) is an orally administered small molecule CGRP receptor antagonist with efficacy in the acute treatment of migraine. Rizatriptan benzoate (MAXALT), is a selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist.

    ✓ Study care freePhase 4Ages 18–65Learn more →
  • Showing the first 60 of 141. Add filters or a location to narrow down.